Carbodiimide crosslinked decellularized lenticules as a drug carrier for sustained antibacterial eye treatments. (1st March 2023)
- Record Type:
- Journal Article
- Title:
- Carbodiimide crosslinked decellularized lenticules as a drug carrier for sustained antibacterial eye treatments. (1st March 2023)
- Main Title:
- Carbodiimide crosslinked decellularized lenticules as a drug carrier for sustained antibacterial eye treatments
- Authors:
- Rao, Jing
Zhou, Qizhi
Chen, Jiansu
Gu, Jianing
Wang, Yini
Liu, Yonghuan - Abstract:
- Abstract: In this study, the drug-loading and antibacterial activity of carbodiimide/N-hydroxysuccinimide (EDC/NHS) crosslinked decellularized lenticules (CDLs) were evaluated. Small incision lenticule extraction derived lenticules were decellularized and modified with crosslinking concentrations of 0.00 (E/L00, non-crosslinked), 0.01 (E/L01), 0.05 (E/L05) and 0.25 mmol (E/L25) EDC per mg lenticules at 5:1 EDC/NHS ratios with non-decellularized non-crosslinked lenticules (NDLs) as controls. NDLs and EDC/NHS CDLs had similar water contents. The light transmittance percentages (400–800 nm) were 91.55 ± 1.16%, 88.68 ± 1.19%, 80.86 ± 1.94%, 85.12 ± 2.42% and 85.62 ± 2.84% for NDLs, E/L00, E/L01, E/L05 and E/L25, respectively ( P < 0.01). The EDC/NHS CDLs (diameter: 6.36 ± 0.18 mm; central thickness: 117.31 ± 3.46 μm) were soaked in 3% (wt./vol.) levofloxacin (LEV) solution for 3 h. The drug release concentrations of LEV-impregnated EDC/NHS CDLs were determined by high-performance liquid chromatography. Zone inhibition (ZOI) against Staphylococcus aureus of E/L01, E/L05 and E/L25 were superior to E/L00 CDLs ( P < 0.01) and among the different crosslinked groups, E/L05 lenticules produced the largest ZOIs and their drug concentration release over 21 d was the highest. EDC/NHS crosslinking can improve the drug-loading effect and antibacterial activity of decellularized lenticules. LEV-impregnated EDC/NHS CDLs are promising drug delivery carriers.
- Is Part Of:
- Biomedical materials. Volume 18:Number 2(2023)
- Journal:
- Biomedical materials
- Issue:
- Volume 18:Number 2(2023)
- Issue Display:
- Volume 18, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 18
- Issue:
- 2
- Issue Sort Value:
- 2023-0018-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-03-01
- Subjects:
- SMILE-derived lenticules -- antibacterial activity -- decellularization -- EDC/NHS crosslinking -- drug sustained release
Biomedical materials -- Periodicals
610.28 - Journal URLs:
- http://www.iop.org/EJ/journal/BMM ↗
http://iopscience.iop.org/1748-605X ↗
http://ioppublishing.org/ ↗ - DOI:
- 10.1088/1748-605X/acb67b ↗
- Languages:
- English
- ISSNs:
- 1748-6041
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25699.xml